{"id":12,"company":{"country":"IL","currency":"USD","exchange":"TEL AVIV STOCK EXCHANGE","ipo":"1951-01-01","marketCap":43299.3,"name":"Teva Pharmaceutical Industries Ltd","phone":"97239267267.0","outstanding":1120.87,"symbol":"TEVA","website":"https://www.tevapharm.com/","industry":"Pharmaceuticals"},"direction":"Long","price":10.58,"year":2023,"month":9,"day":17,"weekday":"Sunday","title":"Influence of geopolitical events on Teva Pharmaceutical Industries Ltd stock markets","date":"2023-09-17","url":"/posts/2023/09/17/TEVA","content":[{"section":"Introduction","text":"Teva Pharmaceutical Industries Ltd is a global pharmaceutical company headquartered in Israel, and its stock markets can be influenced by geopolitical events both within Israel and abroad."},{"section":"Political Developments in Israel","text":"Geopolitical events within Israel, such as elections, changes in government policies, or geopolitical tensions can impact Teva Pharmaceutical Industries Ltd stock markets. Political stability and policy consistency provide a conducive environment for the company, leading to potential market growth."},{"section":"Global Trade Relations","text":"Changes in global trade relations, including trade agreements, trade disputes, or imposition of tariffs, can have an impact on Teva Pharmaceutical Industries Ltd stock markets. The company operates in various countries and is subject to international trade dynamics, such as export/import regulations and supply chain disruptions."},{"section":"Regulatory Changes","text":"Geopolitical events that result in significant regulatory changes in key markets can affect Teva Pharmaceutical Industries Ltd stock markets. Alterations in drug pricing regulations, intellectual property laws, or changes in healthcare policies may impact the company's financial performance and market sentiment."},{"section":"Regional Conflicts or Instability","text":"Teva Pharmaceutical Industries Ltd operates globally, and conflicts or instability in regions where it has a presence can influence its stock markets. Instances of armed conflict, political unrest, or natural disasters can disrupt supply chains, affect market demand, and impact investor confidence."},{"section":"Currency Exchange Rates","text":"Geopolitical events can cause fluctuations in currency exchange rates, impacting Teva Pharmaceutical Industries Ltd stock markets. As a multinational company, the company's revenues and expenses are denominated in different currencies, and fluctuations can affect financial performance and international competitiveness."},{"section":"Public Health Crises","text":"Geopolitical events such as pandemics or global health crises can have significant effects on Teva Pharmaceutical Industries Ltd stock markets. The demand for pharmaceutical products, regulatory measures, and public sentiment regarding healthcare can all be influenced by public health crises, affecting market dynamics."},{"section":"Conclusion","text":"Geopolitical events play a crucial role in influencing the stock markets of Teva Pharmaceutical Industries Ltd. The company's global operations and exposure to various geopolitical factors highlight the need for monitoring political developments, trade relations, regulatory changes, regional conflicts, currency exchange rates, and public health crises to assess potential impacts on the stock markets."}],"tags":["stock","Pharmaceuticals"],"news":[{"category":"company","date":1695931500,"headline":"Teva Announces Changes to Executive Management Team","id":122850510,"image":"https://media.zenfs.com/en/business-wire.com/aac6c577dbb8d60c4c02d1d0e8644445","symbol":"TEVA","publisher":"Yahoo","summary":"TEL AVIV, Israel \u0026 PARSIPPANY, N.J., September 28, 2023--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced changes to its leadership team. Sven Dethlefs, Executive Vice President, North America Commercial, will leave Teva on November 17, 2023, and Christine (Chris) Fox, who most recently served as Global President, Gene Therapies at Novartis will be the new head of Teva’s U.S. Commercial Business. \"On behalf of the Teva Board of Directors and our executive management team","url":"https://finance.yahoo.com/news/teva-announces-changes-executive-management-200500121.html"},{"category":"company","date":1695896220,"headline":"November 10th Options Now Available For Teva Pharmaceutical Industries (TEVA)","id":122847503,"image":"","symbol":"TEVA","publisher":"Stock Options Channel","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3137020334"},{"category":"company","date":1695877740,"headline":"Market Today: Nike's Earnings Beat, Tesla Faces EEOC Lawsuit, and Novartis Executive Joins Teva","id":122847504,"image":"","symbol":"TEVA","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3137588708"},{"category":"company","date":1695871980,"headline":"Teva names Novartis exec to lead US commercial business","id":122846356,"image":"","symbol":"TEVA","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3137447367"},{"category":"company","date":1695870420,"headline":"Teva announces EVP Sven Dethlefs to depart","id":122847506,"image":"","symbol":"TEVA","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3137410497"},{"category":"company","date":1695804780,"headline":"Apple Defends Its $19B Google Search Deal, Hollywood's Writers Secure Credit For AI Training, China's Ambitious Chip Fund Faces Headwinds: Today's Top Stories","id":122804894,"image":"","symbol":"TEVA","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3135151144"},{"category":"company","date":1695800880,"headline":"Migraine Medication Battle: Eli Lilly Prevails in Patent Infringement Case Against Teva","id":122847508,"image":"","symbol":"TEVA","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3135072560"},{"category":"company","date":1695790200,"headline":"Eli Lilly benefits as judge overturns $176.5M verdict in Teva patent case","id":122847509,"image":"","symbol":"TEVA","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3135825627"},{"category":"company","date":1695760432,"headline":"US judge overturns Eli Lilly's $176.5 million loss in Teva patent case","id":122797033,"image":"https://media.zenfs.com/en/reuters-finance.com/0534d7644063ff8bffc0b7c67c4a186e","symbol":"TEVA","publisher":"Yahoo","summary":"Drugmaker Eli Lilly convinced a federal judge in Massachusetts on Tuesday to overturn a $176.5 million jury verdict for Teva Pharmaceutical that found Lilly's migraine drug Emgality infringed three patents related to Teva's rival drug Ajovy.  U.S. District Judge Allison Burroughs said in a post-trial ruling that the Teva patents covering the use of antibodies to inhibit headache-causing peptides were invalid.  \"The Court does not reach this decision nor overturn a jury verdict lightly,\" Burroughs said.","url":"https://finance.yahoo.com/news/us-judge-overturns-eli-lillys-203352787.html"},{"category":"company","date":1695722040,"headline":"Despite Efforts, Vulnerable Patients Still Face Barriers to Essential Medicines, Says New Report","id":122782965,"image":"","symbol":"TEVA","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3133538738"},{"category":"company","date":1695297300,"headline":"Teva put volume heavy and directionally bearish","id":122706864,"image":"","symbol":"TEVA","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3127151394"},{"category":"company","date":1695295320,"headline":"November 3rd Options Now Available For Teva Pharmaceutical Industries","id":122706865,"image":"","symbol":"TEVA","publisher":"Stock Options Channel","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3127108456"},{"category":"company","date":1695274980,"headline":"Analysts’ Top Healthcare Picks: Seelos Therapeutics (SEEL), Clene (CLNN)","id":122701664,"image":"","symbol":"TEVA","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3126726688"},{"category":"company","date":1695252867,"headline":"Unveiling Teva Pharmaceutical Industries (TEVA)'s Value: Is It Really Priced Right? A ...","id":122690734,"image":"https://media.zenfs.com/en/us.finance.gurufocus/cc15b7d28ff5129d33bebe03603f6c61","symbol":"TEVA","publisher":"Yahoo","summary":"Delving into the intrinsic value, financial strength, and growth prospects of Teva Pharmaceutical Industries","url":"https://finance.yahoo.com/news/unveiling-teva-pharmaceutical-industries-teva-233427213.html"},{"category":"company","date":1695190140,"headline":"Teva price target raised to $11 from $8 at UBS","id":122706867,"image":"","symbol":"TEVA","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3125099836"},{"category":"company","date":1695189480,"headline":"Alvotech Humira biosimilar accepted for FDA review","id":122686576,"image":"","symbol":"TEVA","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3125089127"}]}